O	0	4	Anti	Anti	AFX	B-NP
O	4	5	-	-	HYPH	I-NP
O	5	15	metastasis	metastasis	NN	I-NP
O	16	23	effects	effect	NNS	I-NP
O	24	26	of	of	IN	B-PP
O	27	33	gallic	gallic	JJ	B-NP
O	34	38	acid	acid	NN	I-NP
O	39	41	on	on	IN	B-PP
B-Cell	42	49	gastric	gastric	JJ	B-NP
I-Cell	50	56	cancer	cancer	NN	I-NP
I-Cell	57	62	cells	cell	NNS	I-NP
O	63	71	involves	involve	VBZ	B-VP
O	72	82	inhibition	inhibition	NN	B-NP
O	83	85	of	of	IN	B-PP
O	86	88	NF	NF	NN	B-NP
O	88	89	-	-	HYPH	O
O	89	95	kappaB	kappaB	NN	B-NP
O	96	104	activity	activity	NN	I-NP
O	105	108	and	and	CC	O
O	109	123	downregulation	downregulation	NN	B-NP
O	124	126	of	of	IN	B-PP
O	127	131	PI3K	PI3K	NN	B-NP
O	131	132	/	/	SYM	B-NP
O	132	135	AKT	AKT	NN	I-NP
O	135	136	/	/	SYM	B-NP
O	136	141	small	small	JJ	B-NP
O	142	148	GTPase	GTPase	NN	I-NP
O	149	156	signals	signal	NNS	I-NP
O	156	157	.	.	.	O

O	159	170	Polyphenols	Polyphenol	NNS	B-NP
O	171	174	are	be	VBP	B-VP
O	175	182	natural	natural	JJ	B-NP
O	183	195	antioxidants	antioxidant	NNS	I-NP
O	196	200	that	that	WDT	B-NP
O	201	204	are	be	VBP	B-VP
O	205	212	thought	think	VBN	I-VP
O	213	215	to	to	TO	I-VP
O	216	226	contribute	contribute	VB	I-VP
O	227	229	to	to	TO	I-VP
O	230	240	prevention	prevention	VB	I-VP
O	241	243	of	of	IN	B-PP
B-Anatomical_system	244	258	cardiovascular	cardiovascular	JJ	B-NP
O	259	266	disease	disease	NN	I-NP
O	267	270	and	and	CC	O
B-Cancer	271	281	malignancy	malignancy	NN	B-NP
O	281	282	.	.	.	O

O	283	291	Although	Although	IN	B-SBAR
O	292	296	many	many	JJ	B-NP
O	297	304	studies	study	NNS	I-NP
O	305	309	have	have	VBP	B-VP
O	310	314	been	be	VBN	I-VP
O	315	322	carried	carry	VBN	I-VP
O	323	326	out	out	RP	B-PRT
O	327	329	to	to	TO	B-VP
O	330	341	investigate	investigate	VB	I-VP
O	342	345	the	the	DT	B-NP
O	346	361	chemopreventive	chemopreventive	JJ	I-NP
O	362	366	role	role	NN	I-NP
O	367	369	of	of	IN	B-PP
O	370	380	flavonoids	flavonoid	NNS	B-NP
O	380	381	,	,	,	O
O	382	386	less	less	JJR	B-NP
O	387	396	attention	attention	NN	I-NP
O	397	400	has	have	VBZ	B-VP
O	401	405	been	be	VBN	I-VP
O	406	413	focused	focus	VBN	I-VP
O	414	416	on	on	IN	B-PP
O	417	425	phenolic	phenolic	JJ	B-NP
O	426	431	acids	acid	NNS	I-NP
O	431	432	.	.	.	O

O	433	435	In	In	IN	B-PP
O	436	440	this	this	DT	B-NP
O	441	446	study	study	NN	I-NP
O	446	447	,	,	,	O
O	448	451	the	the	DT	B-NP
O	452	455	aim	aim	NN	I-NP
O	456	459	was	be	VBD	B-VP
O	460	462	to	to	TO	B-VP
O	463	474	investigate	investigate	VB	I-VP
O	475	478	the	the	DT	B-NP
O	479	485	effect	effect	NN	I-NP
O	486	488	of	of	IN	B-PP
O	489	497	phenolic	phenolic	JJ	B-NP
O	498	503	acids	acid	NNS	I-NP
O	504	509	found	find	VBN	B-VP
O	510	520	abundantly	abundantly	RB	B-ADVP
O	521	523	in	in	IN	B-PP
B-Organism_subdivision	524	534	vegetables	vegetable	NNS	B-NP
O	534	535	,	,	,	O
O	536	537	i	i	NN	B-NP
O	537	538	.	.	.	O
O	538	539	e	e	NN	B-NP
O	539	540	.	.	.	O
O	541	547	gallic	gallic	JJ	B-NP
O	548	552	acid	acid	NN	I-NP
O	553	554	(	(	(	O
O	554	556	GA	GA	NN	B-NP
O	556	557	)	)	)	O
O	557	558	,	,	,	O
O	559	566	caffeic	caffeic	JJ	B-NP
O	567	571	acid	acid	NN	I-NP
O	572	573	(	(	(	O
O	573	575	CA	CA	NN	B-NP
O	575	576	)	)	)	O
O	577	580	and	and	CC	O
O	581	595	protocatechuic	protocatechuic	JJ	B-NP
O	596	600	acid	acid	NN	I-NP
O	601	602	(	(	(	O
O	602	605	PCA	PCA	NN	B-NP
O	605	606	)	)	)	O
O	606	607	,	,	,	O
O	608	610	on	on	IN	B-PP
O	611	614	the	the	DT	B-NP
O	615	625	inhibition	inhibition	NN	I-NP
O	626	628	of	of	IN	B-PP
B-Cell	629	636	gastric	gastric	JJ	B-NP
I-Cell	637	651	adenocarcinoma	adenocarcinoma	NN	I-NP
I-Cell	652	653	(	(	(	O
I-Cell	653	656	AGS	AGS	NN	B-NP
I-Cell	656	657	)	)	)	O
I-Cell	658	662	cell	cell	NN	B-NP
O	663	673	metastasis	metastasis	NN	I-NP
O	673	674	.	.	.	O

O	675	678	The	The	DT	B-NP
O	679	686	results	result	NNS	I-NP
O	687	693	showed	show	VBD	B-VP
O	694	695	0	0	CD	B-NP
O	695	696	.	.	.	O
O	696	698	01	01	CD	B-NP
O	699	701	mM	mM	NN	I-NP
O	702	704	GA	GA	NN	I-NP
O	705	712	induced	induce	VBD	B-VP
O	713	716	the	the	DT	B-NP
O	717	721	same	same	JJ	I-NP
O	722	727	level	level	NN	I-NP
O	728	730	of	of	IN	B-PP
B-Cell	731	735	cell	cell	NN	B-NP
O	736	744	toxicity	toxicity	NN	I-NP
O	745	747	as	as	IN	B-PP
O	748	749	4	4	CD	B-NP
O	749	750	.	.	.	I-NP
O	750	753	0mM	0mM	NNP	I-NP
O	754	757	PCA	PCA	NNP	I-NP
O	757	758	.	.	.	O

O	759	764	Using	Use	VBG	B-VP
B-Pathological_formation	765	770	wound	wound	NN	B-NP
O	770	771	-	-	HYPH	O
O	771	778	healing	heal	VBG	B-VP
O	779	784	assay	assay	NN	B-NP
O	785	788	and	and	CC	O
O	789	795	Boyden	Boyden	NNP	B-NP
O	796	803	chamber	chamber	NN	I-NP
O	804	809	assay	assay	NN	I-NP
O	809	810	,	,	,	O
O	811	813	GA	GA	NN	B-NP
O	814	817	had	have	VBD	B-VP
O	818	824	potent	potent	JJ	B-NP
O	825	835	inhibitory	inhibitory	JJ	I-NP
O	836	843	effects	effect	NNS	I-NP
O	844	846	on	on	IN	B-PP
B-Cell	847	850	AGS	AGS	NN	B-NP
I-Cell	851	855	cell	cell	NN	I-NP
O	856	865	migration	migration	NN	I-NP
O	865	866	.	.	.	O

O	867	870	The	The	DT	B-NP
O	871	881	expression	expression	NN	I-NP
O	882	884	of	of	IN	B-PP
O	885	888	MMP	MMP	NN	B-NP
O	888	889	-	-	HYPH	B-NP
O	889	890	2	2	CD	I-NP
O	890	891	/	/	SYM	I-NP
O	891	892	9	9	CD	I-NP
O	893	895	of	of	IN	B-PP
B-Cell	896	899	AGS	AGS	NN	B-NP
I-Cell	900	905	cells	cell	NNS	I-NP
O	906	909	was	be	VBD	B-VP
O	910	919	inhibited	inhibit	VBN	I-VP
O	920	922	by	by	IN	B-PP
O	923	924	2	2	CD	B-NP
O	924	925	.	.	.	O
O	925	926	0	0	CD	B-NP
O	927	933	microM	microM	NN	I-NP
O	934	936	of	of	IN	B-PP
O	937	939	GA	GA	NN	B-NP
O	939	940	.	.	.	O

O	941	943	It	It	PRP	B-NP
O	944	946	is	be	VBZ	B-VP
O	947	955	possible	possible	JJ	B-ADJP
O	956	960	that	that	IN	B-SBAR
O	961	964	the	the	DT	B-NP
O	965	976	suppressive	suppressive	JJ	I-NP
O	977	983	effect	effect	NN	I-NP
O	984	986	of	of	IN	B-PP
O	987	989	GA	GA	NN	B-NP
O	990	992	on	on	IN	B-PP
O	993	996	MMP	MMP	NN	B-NP
O	996	997	-	-	HYPH	B-NP
O	997	998	2	2	CD	I-NP
O	998	999	/	/	SYM	I-NP
O	999	1000	9	9	CD	I-NP
O	1001	1006	might	might	MD	B-VP
O	1007	1014	involve	involve	VB	I-VP
O	1015	1018	the	the	DT	B-NP
O	1019	1029	inhibition	inhibition	NN	I-NP
O	1030	1032	of	of	IN	B-PP
O	1033	1035	NF	NF	NN	B-NP
O	1035	1036	-	-	HYPH	B-NP
O	1036	1042	kappaB	kappaB	NN	I-NP
O	1043	1051	activity	activity	NN	I-NP
O	1051	1052	.	.	.	O

O	1053	1061	Multiple	Multiple	JJ	B-NP
O	1062	1070	proteins	protein	NNS	I-NP
O	1071	1079	involved	involve	VBN	B-VP
O	1080	1082	in	in	IN	B-PP
O	1083	1093	metastasis	metastasis	NN	B-NP
O	1094	1097	and	and	CC	O
O	1098	1101	the	the	DT	B-NP
B-Cellular_component	1102	1114	cytoskeletal	cytoskeletal	JJ	I-NP
O	1115	1129	reorganization	reorganization	NN	I-NP
O	1130	1136	signal	signal	NN	I-NP
O	1137	1144	pathway	pathway	NN	I-NP
O	1144	1145	,	,	,	O
O	1146	1155	including	include	VBG	B-PP
O	1156	1159	Ras	Ras	NN	B-NP
O	1159	1160	,	,	,	I-NP
O	1161	1166	Cdc42	Cdc42	NN	I-NP
O	1166	1167	,	,	,	I-NP
O	1168	1172	Rac1	Rac1	NN	I-NP
O	1172	1173	,	,	,	I-NP
O	1174	1178	RhoA	RhoA	NN	I-NP
O	1178	1179	,	,	,	I-NP
O	1180	1184	RhoB	RhoB	NN	I-NP
O	1184	1185	,	,	,	I-NP
O	1186	1190	PI3K	PI3K	NN	I-NP
O	1191	1194	and	and	CC	I-NP
O	1195	1202	p38MAPK	p38MAPK	NN	I-NP
O	1202	1203	,	,	,	O
O	1204	1208	were	be	VBD	B-VP
O	1209	1213	also	also	RB	I-VP
O	1214	1223	inhibited	inhibit	VBN	I-VP
O	1224	1226	by	by	IN	B-PP
O	1227	1229	GA	GA	NN	B-NP
O	1229	1230	.	.	.	O

O	1231	1242	Furthermore	Furthermore	RB	B-ADVP
O	1242	1243	,	,	,	O
O	1244	1260	immunoreactivity	immunoreactivity	NN	B-NP
O	1261	1266	assay	assay	NN	I-NP
O	1267	1269	of	of	IN	B-PP
B-Cellular_component	1270	1282	cytoskeletal	cytoskeletal	JJ	B-NP
O	1283	1284	F	F	NN	I-NP
O	1284	1285	-	-	HYPH	B-NP
O	1285	1290	actin	actin	NN	I-NP
O	1291	1303	demonstrated	demonstrate	VBD	B-VP
O	1304	1305	a	a	DT	B-NP
O	1306	1317	significant	significant	JJ	I-NP
O	1318	1328	inhibitory	inhibitory	JJ	I-NP
O	1329	1335	effect	effect	NN	I-NP
O	1336	1338	of	of	IN	B-PP
O	1339	1341	GA	GA	NN	B-NP
O	1342	1351	treatment	treatment	NN	I-NP
O	1351	1352	.	.	.	O

O	1353	1355	In	In	IN	B-PP
O	1356	1366	conclusion	conclusion	NN	B-NP
O	1366	1367	,	,	,	O
O	1368	1370	GA	GA	NN	B-NP
O	1371	1374	may	may	MD	B-VP
O	1375	1379	have	have	VB	I-VP
O	1380	1383	the	the	DT	B-NP
O	1384	1393	potential	potential	NN	I-NP
O	1394	1396	to	to	TO	B-VP
O	1397	1399	be	be	VB	I-VP
O	1400	1402	an	an	DT	B-NP
O	1403	1412	effective	effective	JJ	I-NP
O	1413	1418	agent	agent	NN	I-NP
O	1419	1422	for	for	IN	B-PP
O	1423	1433	prevention	prevention	NN	B-NP
O	1434	1437	and	and	CC	I-NP
O	1438	1447	treatment	treatment	NN	I-NP
O	1448	1450	of	of	IN	B-PP
B-Cancer	1451	1458	gastric	gastric	JJ	B-NP
I-Cancer	1459	1465	cancer	cancer	NN	I-NP
O	1466	1476	metastasis	metastasis	NN	I-NP
O	1476	1477	.	.	.	O

